LN

Laxmi Negi

Active Director Director DIN 11051609
DIN 11051609 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value •••• Premium profile

About Laxmi Negi

Data last updated:

Laxmi Negi is a Director at Altygen Biopharm Private Limited (since 2025). The company operates in Pharma. Altygen Biopharm Private Limited reported revenue of ₹6.2 Lakh (FY 2024).

DIN 11051609
Primary Designation Director
Industry Pharma
First Appointment 08 Apr 2025
Oldest Company Age 3 yrs
Largest company Altygen Biopharm Private Limited · ₹6.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Altygen Biopharm Private Limited U47721HR2023PTC115382
Director08 Apr 20252023₹6.2 Lakh (FY 2024)Active

Board colleagues of Laxmi Negi

Directorship timeline

Open interactive timeline →
Altygen Biopharm Private Limited
Premium access

Shareholding and investment profile for Laxmi Negi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Laxmi Negi

Laxmi Negi currently holds 1 directorship: Altygen Biopharm Private Limited (Director, since 08 Apr 2025, revenue ₹6.2 Lakh (FY 2024)).

Laxmi Negi was first appointed on 08 Apr 2025 as Director at Altygen Biopharm Private Limited.

The current boards of Laxmi Negi's companies include Deepika (Altygen Biopharm Private Limited), Kamal Deep (Altygen Biopharm Private Limited), Shallini Rai Singhal (Altygen Biopharm Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available